| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.091 | 0.06 |